Literature DB >> 22079320

A single administration of methamphetamine to mice early in the light period decreases running wheel activity observed during the dark period.

Nobue Kitanaka1, Junichi Kitanaka, F Scott Hall, George R Uhl, Kaname Watabe, Hitoshi Kubo, Hitoshi Takahashi, Tomohiro Tatsuta, Yoshio Morita, Motohiko Takemura.   

Abstract

Repeated intermittent administration of amphetamines acutely increases appetitive and consummatory aspects of motivated behaviors as well as general activity and exploratory behavior, including voluntary running wheel activity. Subsequently, if the drug is withdrawn, the frequency of these behaviors decreases, which is thought to be indicative of dysphoric symptoms associated with amphetamine withdrawal. Such decreases may be observed after chronic treatment or even after single drug administrations. In the present study, the effect of acute methamphetamine (METH) on running wheel activity, horizontal locomotion, appetitive behavior (food access), and consummatory behavior (food and water intake) was investigated in mice. A multi-configuration behavior apparatus designed to monitor the five behaviors was developed, where combined measures were recorded simultaneously. In the first experiment, naïve male ICR mice showed gradually increasing running wheel activity over three consecutive days after exposure to a running wheel, while mice without a running wheel showed gradually decreasing horizontal locomotion, consistent with running wheel activity being a positively motivated form of natural motor activity. In experiment 2, increased horizontal locomotion and food access, and decreased food intake, were observed for the initial 3h after acute METH challenge. Subsequently, during the dark phase period decreased running wheel activity and horizontal locomotion were observed. The reductions in running wheel activity and horizontal locomotion may be indicative of reduced dopaminergic function, although it remains to be seen if these changes may be more pronounced after more prolonged METH treatments.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079320      PMCID: PMC4133111          DOI: 10.1016/j.brainres.2011.10.037

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  33 in total

1.  Effect of chronic amphetamine administration on the behaviour of rats in the open field apparatus: reversal of post-withdrawal depression by two antidepressants.

Authors:  M A Lynch; B E Leonard
Journal:  J Pharm Pharmacol       Date:  1978-12       Impact factor: 3.765

2.  Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats.

Authors:  Andre Der-Avakian; Athina Markou
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

3.  Behavioral assessment of high-dose amphetamine withdrawal: importance of training and testing conditions.

Authors:  C W Schindler; A M Persico; G R Uhl; S R Goldberg
Journal:  Pharmacol Biochem Behav       Date:  1994-09       Impact factor: 3.533

4.  Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats.

Authors:  P E Paulson; D M Camp; T E Robinson
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Sensitization of amphetamine-induced wheel running suppression in rats: dose and context factors.

Authors:  C Serwatkiewicz; C Limebeer; R Eikelboom
Journal:  Psychopharmacology (Berl)       Date:  2000-08       Impact factor: 4.530

6.  The reinforcing property and the rewarding aftereffect of wheel running in rats: a combination of two paradigms.

Authors:  Terry W Belke; Jason P Wagner
Journal:  Behav Processes       Date:  2005-02-28       Impact factor: 1.777

7.  Facilitation of sexual behavior in male rats following d-amphetamine-induced behavioral sensitization.

Authors:  D F Fiorino; A G Phillips
Journal:  Psychopharmacology (Berl)       Date:  1999-02       Impact factor: 4.530

8.  Techniques for establishing schedules with wheel running as reinforcement in rats.

Authors:  I H Iversen
Journal:  J Exp Anal Behav       Date:  1993-07       Impact factor: 2.468

9.  Sensitization of psychomotor stimulation and conditioned reward in mice: differential modulation by contextual learning.

Authors:  Andy N Mead; Hans S Crombag; Beatriz A Rocha
Journal:  Neuropsychopharmacology       Date:  2004-02       Impact factor: 7.853

10.  Methamphetamine-induced behavioural effects and brain concentrations of methamphetamine and its metabolite amphetamine in mice.

Authors:  J F Brien; J C Kitney; J E Peachey; B J Rogers
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1978-11
View more
  4 in total

Review 1.  The importance of determining circadian parameters in pharmacological studies.

Authors:  Laetitia S Gaspar; Ana Rita Álvaro; Sara Carmo-Silva; Alexandrina Ferreira Mendes; Angela Relógio; Cláudia Cavadas
Journal:  Br J Pharmacol       Date:  2019-07-06       Impact factor: 8.739

2.  Putting desire on a budget: dopamine and energy expenditure, reconciling reward and resources.

Authors:  Jeff A Beeler; Cristianne R M Frazier; Xiaoxi Zhuang
Journal:  Front Integr Neurosci       Date:  2012-07-20

3.  Assessing mouse behaviour throughout the light/dark cycle using automated in-cage analysis tools.

Authors:  Rasneer S Bains; Sara Wells; Rowland R Sillito; J Douglas Armstrong; Heather L Cater; Gareth Banks; Patrick M Nolan
Journal:  J Neurosci Methods       Date:  2017-04-26       Impact factor: 2.390

4.  Dietary Alaska Pollack Protein Induces Acute and Sustainable Skeletal Muscle Hypertrophy in Rats.

Authors:  Kenji Uchida; Mina Fujitani; Takafumi Mizushige; Fuminori Kawabata; Kohsuke Hayamizu; Keisuke Uozumi; Yuma Hara; Mariko Sawai; Ryota Uehigashi; Shinji Okada; Naoko Goto-Inoue; Mizuki Morisasa; Taro Kishida
Journal:  Nutrients       Date:  2022-01-27       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.